New DNA HIV vaccine shows promise in early safety trial
NCT ID NCT05828095
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This early-stage trial tested a new DNA-based HIV vaccine (INO-6160) alone or with a protein booster in 20 healthy adults without HIV. The main goal was to see if the vaccine is safe and whether it triggers antibodies and T-cells against HIV. The study is complete, and results will help decide if larger trials should move forward.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- DNA vaccine (INO-6160) and protein booster (VRC HIV Env Trimer 4571 with adjuvant)
- What this could lead to
- If successful, this could point toward a safe and effective HIV vaccine that triggers strong immune responses.
- What could go wrong
- This is a very early Phase 1 trial with only 20 participants. It primarily tests safety, not whether the vaccine prevents HIV. Many early vaccine candidates fail to show enough immune response to move forward.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV-1-INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New York Blood Center CRS
New York, New York, 10065, United States
-
Penn Prevention CRS
Philadelphia, Pennsylvania, 19104, United States
-
Vanderbuilt Vaccine (VV) CRS
Nashville, Tennessee, 37232, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single HIV pill tame the epidemic in africa?
- Could a shorter drug course beat a longer one for a deadly fungal infection?
- A kinder, more personal touch may help people with HIV stay in care — a large trial in zambia puts it to the test
- Can tracking HIV's genetic fingerprints reveal where the epidemic is heading?
- Can a new drug, GS-0415, help keep HIV in check? a First-in-Human trial aims to find out
- Could a shot replace daily HIV pills? new trial tests injectable combo